Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers

References

• Merck Sharp & Dohme Corp. Merck Manual Professional Version. New Jersey: Merck Sharp & Dohme Corp; 2021.
   Google Scholar
• Tanaka T. Growth hormone treatment in Japan: past, present, and future. Pediatr Endocrinol Rev. 2012;10(Suppl 1):89–97.
   PubMedGoogle Scholar
• Yokoya S, Tanaka T. The history of growth hormone treatment for GHD in Japan. Pediatr Endocrinol Rev. 2017;14(Suppl 1):201–208. doi:10.17458/per.vol14.2017.yt.historygrowthhormone
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labor and Welfare. Research on the practical infrastructure for the promotion of measures against chronic specific diseases in children. Policy Research Project on Intractable Diseases (Policy Research Project on Intractable Diseases). Study Report. FY2008-2010. Ministry of Health, Labor and Welfare. Available from: https://www.shouman.jp/research/pdf/23_2830/2830_18.pdf. Accessed October 19, 2022.
   Google Scholar
• Ministry of Health, Labor and Welfare. A guide to the diagnosis and treatment of interstitial pituitary dysfunction. FY2008 health and labor sciences research grants for intractable diseases policy research project research: research on pituitary gland dysfunction. Ministry of Health, Labor and Welfare; 2008.
   Google Scholar
• Yakushokushinn / Daiichi-bukai 5seihin no shounin ryoshou koukesshoban-yaku efeint no kyoketsusei noukekkan shougai-go no saihatsu yokusei no kouno tsuika mo [The First Committee of the Pharmaceutical and Food Safety Council approved five products, including an additional indication for the antiplatelet agent Effient to prevent recurrence of ischemic cerebrovascular disease]. Mikusu. Japanese. Available from: https://www.mixonline.jp/tabid55.html?artid=72170. Accessed December 23, 2021.
   Google Scholar
• Lal RA, Hoffman AR. Perspectives on long-acting growth hormone therapy in children and adults. Arch Endocrinol Metab. 2019;63(6):601–607. doi:10.20945/2359-3997000000190
   PubMed Web of Science ®Google Scholar
• Yuen KCJ, Miller BS, Boguszewski CL, et al. Usefulness and potential pitfalls of long-acting growth hormone analogs. Front Endocrinol. 2021;24(12):637209. doi:10.3389/fendo.2021.637209
   Web of Science ®Google Scholar
• Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130:65S–72S. doi:10.1378/chest.130.1_suppl.65S
   PubMed Web of Science ®Google Scholar
• National Institutes for Health and Care Excellence. Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. London: National Institutes for Health and Care Excellence; 2009.
   Google Scholar
• Norgren S. Adherence remains a challenge for patients receiving growth hormone therapy. Pediatr Endocrinol Rev. 2009;6(Suppl 4):545–548.
   PubMedGoogle Scholar
• Mohseni S, Heydari Z, Qorbani M, et al. Adherence to growth hormone therapy in children and its potential barriers. J Pediatr Endocrinol Metab. 2018;31(1):13–20. doi:10.1515/jpem-2017-0157
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Graham S, Weinman J, Auyeung V. Identifying potentially modifiable factors associated with treatment non-adherence in paediatric growth hormone deficiency: a systematic review. Horm Res Paediatr. 2018;90:221–228. doi:10.1159/000493211
   PubMed Web of Science ®Google Scholar
• Tanaka T, Sato T, Yuasa A, et al. Patient preference for growth hormone treatment in Japanese children. Pediatr Int. 2021;63(10):1185–1191. doi:10.1111/ped.14760
   PubMed Web of Science ®Google Scholar
• Graham S, Neo S, Auyeung V, et al. What potentially modifiable factors are associated with treatment nonadherence in pediatric growth hormone deficiency? A quantitative study. Endocr Pract. 2021;27(2):146–151. doi:10.4158/EP-2020-0543
   PubMed Web of Science ®Google Scholar
• Nishinaga H, Kishimoto S, Nishi Y. Survey of growth hormone treatment in clinical practice and patient choice of device. Prog Med. 2015;35:1348–1352.
   Google Scholar
• Kapoor R, Burke S, Sparrow S, et al. Monitoring of concordance in growth hormone therapy. Arch Dis Child. 2008;93:147–148. doi:10.1136/adc.2006.114249
   PubMed Web of Science ®Google Scholar
• Cutfield W, Derraik J, Gunn A, et al. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One. 2011;6:e16223. doi:10.1371/journal.pone.0016223
   PubMed Web of Science ®Google Scholar
• Hartmann K, Ittner J, Müller-Rossberg E, et al. Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders. Horm Res Paediatr. 2013;80:1–5. doi:10.1159/000351800
   PubMed Web of Science ®Google Scholar
• Foo J, Maghnie M, Colao A, et al. Cost-consequence analysis of human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy. Clinicoecon Outcomes Res. 2019;11:525–537. doi:10.2147/CEOR.S195265
   PubMed Web of Science ®Google Scholar
• Tanaka T. International comparison of adult height in children with growth hormone deficiency and limitations of growth hormone treatment in Japan. Pediatr Endocrinol Rev. 2017;14(Suppl 1):216–221. doi:10.17458/per.vol14.2017.t.internationalcomparison
   PubMed Web of Science ®Google Scholar
• Gomez R, Ahmed SF, Maghnie M, et al. Treatment adherence to injectable treatments in pediatric growth hormone deficiency compared with injectable treatments in other chronic pediatric conditions: a systematic literature review. Front Endocrinol. 2022;13:795224. doi:10.3389/fendo.2022.795224
   PubMed Web of Science ®Google Scholar
• Fumio O, Takahashi Y, Tahara S, Ogawa Y, Højby Rasmussen M, Takano K. Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once-weekly somapacitan or daily growth hormone. Clin Endocrinol. 2020;93:620–628. doi:10.1111/cen.14273
   PubMed Web of Science ®Google Scholar
• Tanaka T, Susumu Y, Hoshino Y, et al. Long-term safety and efficacy of daily recombinant human growth hormone treatment in Japanese short children born small for gestational age: final report from an open and multi-center study. Clin Pediatr Endocrinol. 2018;27:145–157. doi:10.1297/cpe.27.145
   PubMedGoogle Scholar
• Japan Marketing Research Association. EphMRA code of conduct (Japanese edition). Japan Marketing Research Association; 2018. Available from: https://www.jmra-net.or.jp/LinkClick.aspx?fileticket=L%2F3co0zdIpM%3D&tabid=466. Accessed June 28, 2021.
   Google Scholar
• Sultan S, El-Hourani M, Rondeau E, et al. Categorizing factors of adherence to parenteral treatment in growth hormone deficiencies and hemophilia: what should be the targets for future research? Patient Prefer Adherence. 2018;12:2039–2063. doi:10.2147/PPA.S177624
   PubMed Web of Science ®Google Scholar
• Maggio M, Vergara B, Porcelli P, et al. Improvement of treatment adherence with growth hormone by easypod™ device experience of an Italian centre. Ital J Pediatr. 2018;44:113–121. doi:10.1186/s13052-018-0548-z
   PubMed Web of Science ®Google Scholar
• Giavoli C, Profka E, Giancola N, et al. Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues. Eur J Endocrinol. 2020;183:L13–L15. doi:10.1530/EJE-20-0481
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Beriowitz DR, Foy CG, Kazis LE, et al. Impact of intensive bIood pressure therapy on patient- reported outcomes. Outcomes results from the SPRINT study (for the SPRINT Study Research Group). N Engl J Med. 2017;377(8):733–744. doi:10.1056/NEJMoa1611179
   PubMed Web of Science ®Google Scholar
• Bress AP, Bellows BK, King J, et al. Cost-effectiveness of intensive versus standard bIood pressure control. N Engl J Med. 2017;377(8):745–755. doi:10.1056/NEJMsa1616035
   PubMed Web of Science ®Google Scholar
• Orimo H, Sato M, Kimur S, et al. Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: an analysis of patient perceptions. Osteoporos Sarcopenia. 2017;3:174–184. doi:10.1016/j.afos.2017.10.002
   PubMedGoogle Scholar
• Tanaka M, Kawakami A, Maeda S, et al. Validity and reliability of the Japanese version of the Morisky Medication Adherence Scale-8 in patients with ulcerative colitis. Gastroenterol Nurs. 2021;44(1):31–38. doi:10.1097/SGA.0000000000000533
   PubMed Web of Science ®Google Scholar
• Furue M, Takeuchi S, Murota H. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol. 2015;172(1):272–275. doi:10.1111/bjd.13377
   PubMed Web of Science ®Google Scholar
• Ichiyama S, Ito M, Funasaka Y. Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities. J Dermatol. 2018;45(6):727–731. doi:10.1111/1346-8138.14225
   PubMed Web of Science ®Google Scholar
• Ikeda N, Kono A. The relationship between health habits, medication adherence, kidney function, and QOL among kidney transplant patients. J Jpn Acad Nurs Sci. 2018;38:365–373. doi:10.5630/jans.38.365
   Google Scholar
• Miyazaki M, Nakashima A, Nakamura Y, et al. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: an observational cross-sectional pilot study. PLoS One. 2018;13(9):e0204814. doi:10.1371/journal.pone.0204814
   PubMed Web of Science ®Google Scholar
• Amereller F, Schillbach K, Schopohl J, et al. Adherence, attitudes and beliefs of growth hormone deficient patients – a questionnaire-based cohort study. Exp Clin Endocrinol Diabetes. 2019;129(2):112–117. doi:10.1055/a-0956-1919
   PubMed Web of Science ®Google Scholar
• Acerini CL, Wac K, Bang P, et al. Optimizing patient management and adherence for children receiving growth hormone. Front Endocrinol. 2017;8:313. doi:10.3389/fendo.2017.00313
   PubMed Web of Science ®Google Scholar
• Goldshtein I, Rouach B, Shamir-Stein N, et al. Role of side effects, physician involvement, and patient perception in non-Adherence with oral bisphosphonates. Adv Ther. 2016;33(8):1374–1384. doi:10.1007/s12325-016-0360-3
   PubMed Web of Science ®Google Scholar
• Świątoniowska-Lonc N, Polański J, Tański W, et al. Impact of satisfaction with physician–patient communication on self-care and adherence in patients with hypertension: cross-sectional study. BMC Health Serv Res. 2020;20(1):1046. doi:10.1186/s12913-020-05912-0
   PubMed Web of Science ®Google Scholar
• Urakami T. Effectiveness of a smartphone application on medication adherence in children with short stature receiving GH therapy: a multicenter prospective cohort study (GTL-App). Clin Pediatr Endocrinol. 2021;30(2):85–92. doi:10.1297/cpe.30.85
   PubMedGoogle Scholar
• Uzoigwe C, Liang Y, Whitmire S, et al. Semaglutide once-weekly persistence and adherence versus other GLP-1 RAs in patients with type 2 diabetes in a US real-world setting. Diabetes Ther. 2021;12(5):1475–1489. doi:10.1007/s13300-021-01053-7
   PubMed Web of Science ®Google Scholar
• Qiao Q, Ouwens MJNM, Grandy S, et al. Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany. Diabetes Metab Syndr Obes. 2016;9:201–205. doi:10.2147/DMSO.S99732
   PubMed Web of Science ®Google Scholar
• Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117–122. doi:10.15386/mpr-1201
   PubMedGoogle Scholar
• Akazawa M, Nomura K, Kusama M, et al. Drug utilization reviews by community pharmacists in Japan: identification of potential safety concerns through the brown bag program. Value Health Reg Issues. 2012;1(1):98–104. doi:10.1016/j.vhri.2012.03.001
   PubMedGoogle Scholar